Physician profile
Audrius Bredikis
NPI 1013091784
$4,131.45
in general payments reported to CMS, 2019-2025
18 companies · $490 in 2025
The $490 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,165 · 2020: $330 · 2021: $587 · 2022: $250 · 2023: $693 · 2024: $615 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,798.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $740.24 | 2021-2025 | Azure Xt Dr Mri Surescan, Pulseselect, Micra |
| Abbott Laboratories | $614.60 | 2019-2024 | Tacticath Ablation Catheter, Sensor Enabled, Advisor, Viewmate |
| Biosense Webster, INC. | $563.49 | 2019-2024 | Nuvision Ice Catheter, Na |
| Boston Scientific Corporation | $491.37 | 2019-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor, Farapulse |
| Novartis Pharmaceuticals Corporation | $344.78 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $192.53 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $186.32 | 2019-2023 | |
| Biotronik INC. | $185.37 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $134.72 | 2019-2023 | Xarelto |
| Atricure, INC. | $119.95 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System, Epi-Sense Guided Coagulation System With Visitrax |
| Inspire Medical Systems, INC. | $105.58 | 2025 | Inspire |
| Amarin Pharma, INC. | $102.01 | 2020-2021 | |
| Irhythm Technologies, INC. | $85.56 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $80.44 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.79 | 2019-2023 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $56.63 | 2019-2020 | |
| Cardiva Medical, INC. | $53.85 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amgen INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrius Bredikis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.